Electroconvulsive therapy in myasthenia gravis

Annals of Clinical Psychiatry

Volumn 16, Issue 4, 2004, Pages 225-227

  Calarge, Chadi A ^a   Crowe, Raymond R ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Depression; Electroconvulsive therapy; Myasthenia gravis; Psychosis

Indexed keywords

AZATHIOPRINE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; PREDNISONE; PSYCHOTROPIC AGENT; PYRIDOSTIGMINE; STEROID;

AGED; CASE REPORT; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; HUMAN; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MUSCLE RELAXATION; MYASTHENIA GRAVIS; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; REVIEW; SAFETY; STEROID THERAPY;

AGED; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; HUMANS; MALE; MYASTHENIA GRAVIS; STEROIDS; TREATMENT OUTCOME;

EID: 10844258197     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.1080/10401230490522052     Document Type: Review

References (17)

1. Weiner RD, Coffey CE, Fotchmann LJ, et al.: The practice of electroconvulsive therapy: Recommendations for treatment, training, and privileging. 2nd ed. Washington, D.C.: American Psychiatric Press; 2001:5-25.
2. Keesey J. Myasthenia gravis. Arch Neurol 1998; 55(5):745-6.
3. Jaretzki A, 3rd, Barohn RJ, Ernstoff RM, et al.: Myasthenia gravis: Recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 2000; 55(1):16-23.
4. Osserman KE, Genkins G.: Studies in myasthenia gravis: Review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971; 38(6):497-537.
5. Martin RD, Flegenheimer WV: Psychiatric aspects of the management of the myasthenic patient. Mt Sinai J Med 1971; 38(6):594-601.
6. Pande AC, Grunhaus LJ: ECT for depression in the presence of myasthenia gravis. Convulsive Therapy 1990; 6(2):172-175.
7. Gitlin MC, Jahr JS, Margolis MA, McCain J: Is mivacurium chloride effective in electroconvulsive therapy? A report of four cases, including a patient with myasthenia gravis. Anesth Analg 1993; 77(2):392-4.
8. Sackeim HA, Prudic J, Devanand DP, et al.: A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000; 57(5):425-34.
9. Leventhal SR, Orkin FK, Hirsh RA: Prediction of the need for postoperative mechanical ventilation in myasthenia gravis. Anesthesiology 1980; 53(1):26-30.
10. Eisenkraft SR, Papatestas AE, Pozner JN: Predictors of respiratory failure following transcervical thymectomy. Annals of New York Academy of Sciences 1987; 505:888-890.
11. Sunew KY, Hicks RG: Effects of neostigmine and pyridostigmine on duration of succinylcholine action and pseudocholinesterase activity. Anesthesiology 1978; 49(3):188-91.
12. Stirt JA, Sperry RJ, DiFazio CA: Cimetidine and succinylcholine: Potential interaction and effect on neuromuscular blockade in man. Anesthesiology 1988; 69(4):607-8.
13. Viby-Mogensen J: Interaction of other drugs with muscle relaxants. Semin Anesth. 1985; 4:52-64.
14. Savarese JJ, Caldwell JE, Lien CA: Pharmacology of muscle relaxants and their antagonists. In: Miller RD, ed. Anesthesia. 5 ed. Philadelphia, PA: Churchill Livingstone Inc.; 2000:470-471.
15. Baraka A. Anesthesia and myasthenia gravis. Middle East J Anesthesiol. 1993; 12(1):9-35.
16. Eisenkraft JB, Book WJ, Mann SM, Papatestas AE, Hubbard M: Resistance to succinylcholine in myasthenia gravis: A dose-response study. Anesthesiology. 1988; 69(5):760-3.
17. Hagan JA, Cooper JD: Surgical management of myasthenia gravis. In: Sabiston DCJ, Lyerly KH, eds. Textbook of surgery: The biological basis of modern surgical practice. 15 ed. Philadelphia, PA: W.B. Saunders Company.; 1997:1933-1941.